Pharmacobiology Department, CINVESTAV-IPN, Calz. de los Tenorios 235, Col. Granjas Coapa, Mexico City, Mexico.
J Physiol Biochem. 2011 Sep;67(3):427-35. doi: 10.1007/s13105-011-0093-3. Epub 2011 Apr 15.
The contribution of α-adrenoceptors and nitric oxide (NO) on the alterations of sympathetically mediated cardiovascular responses after acute (AcH) and chronic (ChH) hypertension was evaluated in pithed aortic coarcted hypertensive rats. Pressor and tachycardia response produced by electrical stimulation of preganglionic sympathetic fibers or exogenous noradrenaline (NA) were recorded in the absence and presence of prazosin (α(1)-antagonist), rauwolscine (α(2)-antagonist), or N (G)-nitro-L-arginine methyl ester (L-NAME; an inhibitor of NO synthase). Compared with age-matched sham-operated rats (Nt), the pressor response produced by electrical stimulation or NA was smaller in AcH rats and larger in ChH rats. Prazosin caused a decrease of pressor response elicited by electrical stimulation or NA in all groups. However, this effect was higher in ChH. Rauwolscine produced a similar increase of sympathetically mediated pressor response in Nt and AcH rats. Nevertheless, this antagonist did not affect the sympathetically mediated pressor response in ChH rats. In addition, rauwolscine did not affect the NA-induced pressor response in all groups. The pressor response elicited by L-NAME was larger in all groups compared without L-NAME and in presence of L-arginine. Moreover, L-NAME in the presence of NA increased sympathetically mediated pressor response is in all groups, compared without it or in the presence of L-arginine. Compared with Nt, basally produced NO in aortic rings was increased in AcH but decreased in ChH. Collectively, our data suggest that decreased cardiovascular reactivity in AcH is due to an increase in basally produced NO. In ChH, enhanced cardiovascular response appears to be associated with a decrease in produced NO and an increase in released NA from sympathetic nerves.
在去顶的腹主动脉缩窄高血压大鼠中,评估了α-肾上腺素能受体和一氧化氮 (NO) 在急性 (AcH) 和慢性 (ChH) 高血压后交感神经介导的心血管反应改变中的作用。在不存在和存在哌唑嗪(α(1)-拮抗剂)、劳洛昔芬(α(2)-拮抗剂)或 N(G)-硝基-L-精氨酸甲酯 (L-NAME;一氧化氮合酶抑制剂)的情况下,记录了节前交感神经纤维电刺激或外源性去甲肾上腺素 (NA) 产生的升压和心动过速反应。与年龄匹配的假手术大鼠 (Nt) 相比,电刺激或 NA 产生的升压反应在 AcH 大鼠中较小,在 ChH 大鼠中较大。哌唑嗪在所有组中均引起电刺激或 NA 引起的升压反应减少。然而,这种作用在 ChH 中更高。劳洛昔芬在 Nt 和 AcH 大鼠中产生了类似的增加交感神经介导的升压反应。然而,这种拮抗剂在 ChH 大鼠中不影响交感神经介导的升压反应。此外,劳洛昔芬在所有组中均不影响 NA 引起的升压反应。在没有 L-NAME 和存在 L-精氨酸的情况下,L-NAME 引起的升压反应在所有组中均大于没有 L-NAME 和存在 L-精氨酸的情况下。此外,在所有组中,L-NAME 存在时 NA 增加了交感神经介导的升压反应,与不存在 L-NAME 或存在 L-精氨酸时相比。与 Nt 相比,AcH 中主动脉环中基础产生的 NO 增加,而 ChH 中则减少。总的来说,我们的数据表明,AcH 中心血管反应性降低是由于基础产生的 NO 增加所致。在 ChH 中,增强的心血管反应似乎与产生的 NO 减少和从交感神经释放的 NA 增加有关。